Transcutaneous neuromodulation device
Chu , et al. June 15, 2
U.S. patent number D922,592 [Application Number D/693,183] was granted by the patent office on 2021-06-15 for transcutaneous neuromodulation device. This patent grant is currently assigned to Apex Neuro Holdings, Inc.. The grantee listed for this patent is Apex Neuro Inc.. Invention is credited to Geoff Baldwin, Zen Chu, Sean Hagberg, Francois Kress, Jainam Shah, Priyanka Venkatesh.
| United States Patent | D922,592 |
| Chu , et al. | June 15, 2021 |
Transcutaneous neuromodulation device
Claims
CLAIM The ornamental design for a transcutaneous neuromodulation device, substantially as shown and described.
| Inventors: | Chu; Zen (Brookline, MA), Hagberg; Sean (Cranston, RI), Kress; Francois (New York, NY), Shah; Jainam (Cambridge, MA), Baldwin; Geoff (Cambridge, MA), Venkatesh; Priyanka (New York, NY) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Applicant: |
|
||||||||||
| Assignee: | Apex Neuro Holdings, Inc.
(Brooklyn, NY) |
||||||||||
| Appl. No.: | D/693,183 | ||||||||||
| Filed: | May 31, 2019 |
| Current U.S. Class: | D24/200 |
| Current International Class: | 2803 |
| Field of Search: | ;D24/200,185-187,214,107 |
References Cited [Referenced By]
U.S. Patent Documents
| 6077237 | June 2000 | Campbell |
| D615209 | May 2010 | Minogue |
| 8682452 | March 2014 | Minogue |
| 8914123 | December 2014 | Rigaux |
| D752766 | March 2016 | Guarraia |
| D816227 | April 2018 | Geissen |
| 10695568 | June 2020 | Covalin |
| 10828461 | November 2020 | Cartledge |
| 2008/0097549 | April 2008 | Colbaugh |
| 2019/0232046 | August 2019 | Chu |
| 2019/0232047 | August 2019 | Chu |
| 2020/0338348 | October 2020 | Honeycutt |
| 2021/0060330 | March 2021 | Chu |
Attorney, Agent or Firm: Hassid; Steve Partners Law Group Inc.
Description
FIG. 1 is a perspective view of a transcutaneous neuromodulation device according to our new design, where the device generally comprises a headband for engaging wearer's head and ear hook's to generally align interface components of the device with mastoid locations on the wearer.
FIG. 2 is another perspective view thereof.
FIG. 3 is another perspective view thereof.
FIG. 4 is another perspective view thereof which the headband is shown in expanded form (e.g., to accommodate a larger head of a wearer).
FIG. 5 is another perspective view thereof.
FIG. 6 is another perspective view thereof; and,
FIG. 7 is another perspective view thereof.
The features shown in broken lines in various figures are for illustrating portions of the transcutaneous neuromodulation device and form no part of the claimed design.
* * * * *
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 